BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 28938007)

  • 21. Hematopoietic stem cell gene therapy targeting TGFβ enhances the efficacy of irradiation therapy in a preclinical glioblastoma model.
    Andreou T; Williams J; Brownlie RJ; Salmond RJ; Watson E; Shaw G; Melcher A; Wurdak H; Short SC; Lorger M
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33707311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma.
    Martini M; de Pascalis I; D'Alessandris QG; Fiorentino V; Pierconti F; Marei HE; Ricci-Vitiani L; Pallini R; Larocca LM
    BMC Cancer; 2018 May; 18(1):553. PubMed ID: 29747600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of functional normalisation of tumour vessels following anti-angiogenic therapy in glioblastoma.
    Obad N; Espedal H; Jirik R; Sakariassen PO; Brekke Rygh C; Lund-Johansen M; Taxt T; Niclou SP; Bjerkvig R; Keunen O
    J Cereb Blood Flow Metab; 2018 Oct; 38(10):1741-1753. PubMed ID: 28627960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropilin 1 balances β8 integrin-activated TGFβ signaling to control sprouting angiogenesis in the brain.
    Hirota S; Clements TP; Tang LK; Morales JE; Lee HS; Oh SP; Rivera GM; Wagner DS; McCarty JH
    Development; 2015 Dec; 142(24):4363-73. PubMed ID: 26586223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Talin1 targeting potentiates anti-angiogenic therapy by attenuating invasion and stem-like features of glioblastoma multiforme.
    Kang W; Kim SH; Cho HJ; Jin J; Lee J; Joo KM; Nam DH
    Oncotarget; 2015 Sep; 6(29):27239-51. PubMed ID: 26336988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy.
    Lucio-Eterovic AK; Piao Y; de Groot JF
    Clin Cancer Res; 2009 Jul; 15(14):4589-99. PubMed ID: 19567589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
    Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoglobulin Fc-fused, neuropilin-1-specific peptide shows efficient tumor tissue penetration and inhibits tumor growth via anti-angiogenesis.
    Kim YJ; Bae J; Shin TH; Kang SH; Jeong M; Han Y; Park JH; Kim SK; Kim YS
    J Control Release; 2015 Oct; 216():56-68. PubMed ID: 26260451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms.
    Miletic H; Niclou SP; Johansson M; Bjerkvig R
    Expert Opin Ther Targets; 2009 Apr; 13(4):455-68. PubMed ID: 19335067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical impact of bevacizumab on brain and tumor distribution of irinotecan and temozolomide.
    Goldwirt L; Beccaria K; Carpentier A; Idbaih A; Schmitt C; Levasseur C; Labussiere M; Milane A; Farinotti R; Fernandez C
    J Neurooncol; 2015 Apr; 122(2):273-81. PubMed ID: 25794638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutrophils promote the malignant glioma phenotype through S100A4.
    Liang J; Piao Y; Holmes L; Fuller GN; Henry V; Tiao N; de Groot JF
    Clin Cancer Res; 2014 Jan; 20(1):187-98. PubMed ID: 24240114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.
    Zhou R; Curry JM; Roy LD; Grover P; Haider J; Moore LJ; Wu ST; Kamesh A; Yazdanifar M; Ahrens WA; Leung T; Mukherjee P
    Oncogene; 2016 Oct; 35(43):5608-5618. PubMed ID: 26804176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-regulatory factor-1 (IRF1) regulates bevacizumab induced autophagy.
    Liang J; Piao Y; Henry V; Tiao N; de Groot JF
    Oncotarget; 2015 Oct; 6(31):31479-92. PubMed ID: 26362401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiangiogenic therapy for high-grade glioma.
    Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
    Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of the TGFβ pathway in the regulation of α5 β1 integrins by caveolin-1 in human glioblastoma.
    Cosset EC; Godet J; Entz-Werlé N; Guérin E; Guenot D; Froelich S; Bonnet D; Pinel S; Plenat F; Chastagner P; Dontenwill M; Martin S
    Int J Cancer; 2012 Aug; 131(3):601-11. PubMed ID: 21901744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble CD146, a biomarker and a target for preventing resistance to anti-angiogenic therapy in glioblastoma.
    Joshkon A; Tabouret E; Traboulsi W; Bachelier R; Simoncini S; Roffino S; Jiguet-Jiglaire C; Badran B; Guillet B; Foucault-Bertaud A; Leroyer AS; Dignat-George F; Chinot O; Fayyad-Kazan H; Bardin N; Blot-Chabaud M
    Acta Neuropathol Commun; 2022 Oct; 10(1):151. PubMed ID: 36274147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice.
    de Groot JF; Fuller G; Kumar AJ; Piao Y; Eterovic K; Ji Y; Conrad CA
    Neuro Oncol; 2010 Mar; 12(3):233-42. PubMed ID: 20167811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bevacizumab changes vascular structure and modulates the expression of angiogenic factors in recurrent malignant gliomas.
    Okamoto S; Nitta M; Maruyama T; Sawada T; Komori T; Okada Y; Muragaki Y
    Brain Tumor Pathol; 2016 Apr; 33(2):129-36. PubMed ID: 26826105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Kinase Signaling in Resistance to Bevacizumab Therapy for Glioblastoma Multiforme.
    Ramezani S; Vousooghi N; Joghataei MT; Chabok SY
    Cancer Biother Radiopharm; 2019 Aug; 34(6):345-354. PubMed ID: 31411929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines.
    Gallo-Oller G; Vollmann-Zwerenz A; Meléndez B; Rey JA; Hau P; Dotor J; Castresana JS
    Cancer Lett; 2016 Oct; 381(1):67-75. PubMed ID: 27473823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.